| Chemical Properties | Back Directory | [Melting point ]
83-85 °C | [Boiling point ]
565.4±40.0 °C(Predicted) | [density ]
0.983±0.06 g/cm3(Predicted) | [pka]
9.76±0.20(Predicted) | [InChI]
InChI=1S/C24H41NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-24(27)25-20-21-17-18-22(26)23(19-21)28-2/h17-19,26H,3-16,20H2,1-2H3,(H,25,27) | [InChIKey]
SGEUEXJZQFSBNX-UHFFFAOYSA-N | [SMILES]
C(NCC1=CC=C(O)C(OC)=C1)(=O)CCCCCCCCCCCCCCC |
| Hazard Information | Back Directory | [Uses]
Palvanil is a Capsaicin.html" class="link-product" target="_blank">Capsaicin (HY-10448) analogue, shows strong desensitizing capability against the TRPV1 receptor. Palvanil shows anti-nociceptive and anti-inflammation effects[1][2]. | [in vivo]
Palvanil (subcutaneous injection; 1 or 10 mg/kg; once) treatment shows hypothermic effect[2].
Palvanil (intraperitoneal injection; 100 μL (15 nM) per mouse; once) treatment reduces Capsaicin-induced bronchoconstriction[2].
Palvanil (intravenous injection; 0.5, 0.75, and 1 mg/kg; once) treatment shows antinociceptive effects on Formalin-induced nocifensive behavior[2].
Palvanil (intravenous injection; 0.5, 0.75, and 1 mg/kg; once) treatment inhibits Carrageenan-induced inflammation[2].
Palvanil (intravenous injection; 0.5 and 1 mg/kg; once daily; 7 days) reduces mechanical allodynia and thermal hyperalgesia in spared nerve injury (SNI) mice[2]. | Animal Model: | Male CD-1 mice[2] | | Dosage: | 1 or 10 mg/kg | | Administration: | Subcutaneous injection; 1 or 10 mg/kg; once | | Result: | Led to a slight and short lasting hypothermic effect, produced late hyperthermia. |
| Animal Model: | Female BALB/C mice[2] | | Dosage: | 100 μL (15 nM) per mouse | | Administration: | Intraperitoneal injection; 100 μL (15 nM) per mouse; once | | Result: | Induced a significantly lower bronchoconstriction (from 0.47 to 0.605 cm H2O/L/s). |
| Animal Model: | Male CD-1 mice received formalin[2] | | Dosage: | 0.5, 0.75, and 1 mg/kg | | Administration: | Intravenous injection; 0.5, 0.75, and 1 mg/kg; once | | Result: | Reduced the second phase of Formalin-induced nociceptive behaviour in a dose-dependent manner. |
| Animal Model: | Male C57BL/6J mice with acute inflammation induced by Carrageenan[2] | | Dosage: | 2.5 mg/kg | | Administration: | Intravenous injection; 2.5 mg/kg; once | | Result: | Reduced the volume of the oedema in the ipsilateral hind paw (64%). |
| Animal Model: | Male CD-1 mice[2] | | Dosage: | 0.5 and 1 mg/kg | | Administration: | Intravenous injection; 0.5 and 1 mg/kg; once daily; 7 days | | Result: | Reduced mechanical allodynia and thermal hyperalgesia at 3 and 7 days after nerve injury in a dose-dependent manner. |
| [References]
[1] Luciano De Petrocellis, et al. N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. Pharmacol Res. 2011 Apr;63(4):294-9. DOI:10.1016/j.phrs.2010.12.019
[2] Livio Luongo, et al. Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature. Pharmacol Res. 2012 Sep;66(3):243-50. DOI:10.1016/j.phrs.2012.05.005 |
|
| Company Name: |
Henan Alfachem Co.,Ltd.
|
| Tel: |
0371-55051623 18137891487 |
| Website: |
www.chemicalbook.com/supplier/14555231/ |
|